PELICAN POINT CAPITAL PARTNERS, LLC., IS PLEASED TO ANNOUNCE THAT ROGER GUNNARSSON JOINS ITS ADVISORY BOARD AS AN ADVISER IN ITS EFFORT IN LIFE SCIENCE AND HEALTHCARE VENTURES.

Newport Beach, CA (January 22, 2014) – Pelican Point Capital Partners, LLC., announces the appointment of Roger Gunnarsson as an adviser to its board. “Roger’s extensive background in healthcare investment banking with top global firms as well as coverage of some of the most sophisticated and successful pharma/biotech/med-tech companies will further our firms Merchant Banking efforts in the Life Science and Healthcare sectors,” said Ike Suri, Co CEO and Co Founder.

Roger was most recently the Head of Healthcare Investment Banking in Europe, Middle East and Africa for Barclays Investment Bank. There, he founded the EMEA healthcare team and within three years, built if from scratch to one of the largest and most profitable healthcare groups in Europe. During Roger’s career he has held senior posts with Barclays, Lehman Brothers, Merrill Lynch and SBC Warburg (now UBS) providing public and private M&A (buy-side & sell-side), restructuring, equity and debt financing, venture financing and derivatives including incentive payments structuring allowing him to be an incredibly resourceful force for his clients.

Roger’s has advised companies such as GlaxoSmithKline, Novartis, Roche, Pfizer, UCB, CSL and Dako to name a few, his deal making and execution track record coupled with his contacts and relationships throughout his career will be a key component for Pelican Point Capital as we grow our presence in the Life Sciences and healthcare space.